Healthcare Services

Barry Blake is the Global Co-Head of Investment Banking and Global Co-Head of Healthcare Investment Banking at SVB Securities. In this role, Mr. Blake co-leads the firm’s healthcare investment banking strategy and initiatives, with a focus on Healthcare Services & Technology. With 25 years of experience, Mr. Blake has built extensive relationships and has proven expertise in healthcare services, leveraged finance and with financial sponsors.

Mr. Blake joined the firm in 2021 from Guggenheim Securities where he was a Senior Managing Director focused on advising healthcare services companies. While at Guggenheim, Mr. Blake worked on many transactions including, but not limited to, the $10B sale of Envision to KKR; the $4B sale of Kindred Healthcare to a consortium comprised of TPG, Welsh Carson and Humana; the $2.4B sale of American Medical Response to KKR and the $1B sale of Almost Family to LHC Group. Prior to this, Mr. Blake was the Head of Global Healthcare Mergers and Acquisitions for Citigroup and worked in the M&A and Healthcare groups at JP Morgan and Lehman Brothers.

Mr. Blake earned his Bachelor of Arts in Economics from Hendrix College, and his Masters of Business Administration from the Amos Tuck School at Dartmouth College.

He serves as a member of the Board of Trustees for each of The Hopkins School in New Haven, CT and Hendrix College in Conway, AR.

Jed Brody is a Senior Managing Director of Healthcare Investment Banking at SVB Securities. With over 20 years of experience, Mr. Brody will lead the firm’s M&A advisory business across major sectors of healthcare, including healthcare-focused private equity.

Mr. Brody joined the firm in 2021 from Barclays where he most recently was Co-Head of Healthcare Americas and Global Head of Healthcare M&A. While at Barclays, Mr. Brody worked on many transactions including, but not limited to, CVS Health’s $69 billion acquisition of Aetna, ICU Medical’s $2.35 billion acquisition of Smiths Medical, the sale of Equian to UnitedHealth Group for $2.35 billion, the sale of Kindred Healthcare to Lifepoint, Sun Life’s $2.5 billion acquisition of DentaQuest, Centene’s $17.3 billion acquisition of WellCare. Prior to this, Mr. Brody was at Lehman Brothers.

Mr. Brody earned his BS in Finance from Lehigh University.

Mr. Brown is a Senior Managing Director of Investment Banking at SVB Securities, leading the firm’s efforts in pharma services and pharma IT. He brings over 20 years of broad experience in healthcare services M&A and equity capital markets, advising public, sponsor-backed and founder-owned companies globally.

Mr. Brown joined the firm in 2021 after over 15 years at Baird, where he served as a Managing Director and Head of Global Pharma Services Investment Banking, leading M&A and capital raising efforts across the vertical. Prior to leading the Pharma Services group, Mr. Brown had coverage responsibility for a variety of healthcare verticals at Baird, including HCIT and Payor & Employer services. Prior to that, Mr. Brown held investment banking and private equity positions with Thomas Weisel Partners, The Halifax Group, Growth Capital Partners, and Prudential Capital Group.

Mr. Brown earned his Bachelor of Business Administration from Southern Methodist University and his M.B.A. at Northwestern University – Kellogg School of Management.

Jeff Danesis is a Senior Managing Director of Investment Banking at SVB Securities and oversees the firm’s Physician Services Investment Banking franchise.

Mr. Danesis’ career spans over 15 years of healthcare investment banking expertise and over 40 closed transactions. He has extensive deal experience in physician-centric businesses with a particular emphasis on physician practice management and outpatient provider models. Notable recent transactions include advising Waypoint Capital on its acquisition of a majority ownership stake in Allergy Partners, Truvista Ophthalmology Surgical Center and select affiliated physician practices on its sale to Sunvera Group (a Ridgemont Equity Partners portfolio company), Prism Medical Products on its sale to Henry Schein, Green Bay Radiology on its partnership with Lucid Health (an Excellere Partners portfolio company), Austin Radiological Association on its partnership with Radiology Partners; the recapitalization of Dermatologists of Central States by Sheridan Capital Partners; the recapitalization of Charlotte Radiology by Welsh, Carson, Anderson & Stowe to form U.S. Radiology Specialists; the sale of Midwest Center for Dermatology and Cosmetic Surgery to an undisclosed financial sponsor-backed buyer; and the sale of Cleveland HeartLab by Quest Diagnostics.

Prior to joining the firm in 2014, Mr. Danesis was a Director in the Healthcare Group at Lazard and a member of the Healthcare Investment Banking Group at Wachovia Securities.

Mr. Danesis earned his M.B.A. from the University of Chicago and his B.A. from Northwestern University.

Howard Dingle is a Senior Managing Director of Investment Banking at SVB Securities covering healthcare distribution, technology, and related services.

Mr. Dingle joined the firm in 2021 from RBC Capital Markets where he spent more than eight years and most recently served as Managing Director of Healthcare Investment Banking where he lead coverage of healthcare distribution, technology, and related services companies. Prior to RBC Capital Markets, Mr. Dingle held positions at Credit Suisse and Deloitte.

Mr. Dingle earned his Bachelor of Science at Lehigh University and his M.B.A. at The University of Chicago Booth School of Business.  He is a member of the Lehigh University Wall Street Council and a member of the Manhattan Institute’s Young Leaders Circle Advisory Committee.

Robert Jackey is a Senior Managing Director in Investment Banking at SVB Securities and is focused on coverage for Physician Services and Healthcare Provider companies. With over 16 years of Healthcare Investment Banking experience, Mr. Jackey has led efforts to execute strategic transactions for a variety of public and private companies. His advisory and execution experience spans the spectrum of traditional provider organizations through high-growth healthcare disruptors, including domestic and multinational corporations.

Mr. Jackey joined SVB Securities in 2021 from Citigroup, where he spent over 16 years, most recently as Managing Director, covering the alternate site / sub-acute, behavioral, clinical staffing / outsourcing, dental, hospital / acute care, patient transportation, physician organization and veterinary verticals.

Mr. Jackey holds a B.S. (summa cum laude) in electrical engineering as well as an M.B.A. from Fairleigh Dickinson University.

M. Toby King is a Senior Managing Director of Investment Banking at SVB Securities. He is focused on the provider, outsourcing and post-acute care sectors. Over his 20 year career, Mr. King has advised many of the industry’s leading healthcare companies and private equity firms.

Mr. King joined the firm in 2021 from Citigroup where he spent more than a decade and most recently served as Managing Director and Head of North America Healthcare leading efforts with individual coverage across hospitals, alternate-site providers, behavioral health, outsourcing and post-acute care. Prior to Citigroup, Mr. King spent more than ten years in the healthcare group at Merrill Lynch.

Prior to starting his career in investment banking, Mr. King worked for HCA Healthcare in Corporate Finance and Business Development.

Mr. King earned his Bachelor of Arts at Bellarmine University in Louisville, Kentucky and his M.B.A. at The University of Chicago’s Booth School of Business.

Stephanie Davis is a Senior Research Analyst at SVB Securities covering Healthcare Technology and Distribution. She has over a decade of experience covering the Healthcare IT and IT Services sectors and leads the firm’s digital health research efforts.

Prior to joining the firm, Ms. Davis worked at Citibank where she led coverage for the Healthcare IT sector, including the electronic health record companies, payer-facing and provider-facing IT players. Before Citi, Ms. Davis was an Equity Research Analyst at J.P. Morgan and, earlier in her career, was an Investment Banking Analyst at Sonenshine Partners.

In 2019, Ms. Davis was recognized as a Runner-Up for Health Care Technology and Distribution on Institutional Investor’s All America Research Team and was included in Business Insider’s “Rising Stars of Equity Research” in 2017.

Ms. Davis earned a B.A. in Economics and Mathematics from Columbia University and is a CFA charterholder.

Whit Mayo is a Senior Managing Director and Senior Research Analyst covering Healthcare Providers & Managed Care at SVB Securities. He leads SVB Securities’s research across payors, providers, and health systems and provides strategic guidance and insight for our clients and partners.

Mr. Mayo joined the firm in 2021 from UBS, where he most recently served as Managing Director. Prior to that, he covered the sector at Baird and Stephens, Inc.

In 2020 he was ranked in Institutional Investor’s All-America Research Team within the Health Care Facilities & Managed Care category.

He earned his Bachelor of Arts in Economics at Sewanee, The University of the South.